During the past decade, Clinical Applications Laboratories, Inc. conducted 15 clinical trials. In the 10-year time frame, 15 clinical trials started and 14 clinical trials were completed, i.e. on average, 93.3% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 10 clinical trials were completed. i.e. 333.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Clinical Applications Laboratories, Inc." #1 sponsor was "Eli Lilly and Company" with 3 trials, followed by "Pfizer" with 3 trials sponsored, "Allergan" with 2 trials sponsored, "Alvine Pharmaceuticals Inc." with 2 trials sponsored and "Hoffmann-La Roche" with 2 trials sponsored. Other sponsors include 9 different institutions and companies that sponsored additional 15 trials in total.

According to Clinical.Site data, the most researched conditions in "Clinical Applications Laboratories, Inc." are "Ulcerative Colitis" (11 trials), "Celiac Disease" (2 trials), "Colitis, Ulcerative" (2 trials), "Crohn Disease" (2 trials) and "Crohn's Disease" (2 trials). Many other conditions were trialed in "Clinical Applications Laboratories, Inc." in a lesser frequency.

Most popular intervention types in "Clinical Applications Laboratories, Inc." are "Drug" (25 trials) and "Other" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (13 trials), "CP-690,550" (2 trials), "Guselkumab Dose 1" (2 trials), "Guselkumab Dose 2" (2 trials) and "Guselkumab Dose 3" (2 trials). Other intervention names were less common.

The vast majority of trials in "Clinical Applications Laboratories, Inc." are 25 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Clinical Applications Laboratories, Inc.". undefined are not yet recruiting, 4 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 14 completed trials in Clinical Applications Laboratories, Inc., undefined suspended trials, and 5 terminated clinical trials to date.

Out of the total trials that were conducted in Clinical Applications Laboratories, Inc., 3 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 16 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 4 trials, and there were also 0 trials that are defined as “Not Applicable".